Yes, it was oversold down. Vertex will continue to bring in at least $1.5B in revenue a year for many years to come in either Hep C drugs or Cystic Fibrosis drugs. And that is just the base. Other drugs and stronger sales will be on top of that. Vertex is a growing company pure and simple. They know their science and how to bring drugs through trial, to FDA approval and market. Very good company.